丰原药业(000153.SZ)：前三季净利润1亿元 同比下降31.92%

Core Viewpoint - Fengyuan Pharmaceutical (000153.SZ) reported a decline in both revenue and net profit for the first three quarters of the year, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for the first three quarters was 3.125 billion yuan, a year-on-year decrease of 4.18% [1] - The net profit attributable to shareholders was 100 million yuan, reflecting a year-on-year decline of 31.92% [1] - The net profit excluding non-recurring gains and losses was 74.915 million yuan, down 36.39% year-on-year [1]